Mn Services Vermogensbeheer B.V. Alnylam Pharmaceuticals, Inc. Put Options Transaction History
Mn Services Vermogensbeheer B.V.
- $14.8 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALNY
# of Institutions
670Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$3.96 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.04 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.28 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.66 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.05 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...